Breast Protocol - S1207

S1207

"Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive, and HER2/Neu Negative Breast Cancer. e3 Breast Cancer Study - evaluating everolimus with endocrine therapy."